Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells  by Kuroda, R. et al.
OsteoArthritis and Cartilage (2007) 15, 226e231
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.joca.2006.08.008Brief report
Treatment of a full-thickness articular cartilage defect in the femoral
condyle of an athlete with autologous bone-marrow stromal cells1
R. Kuroda M.D.y*, K. Ishida M.D.y, T. Matsumoto M.D.y, T. Akisue M.D.y, H. Fujioka M.D.y,
K. Mizuno M.D.y, H. Ohgushi M.D.z, S. Wakitani M.D.x and M. Kurosaka M.D.y
yDepartment of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Japan
zResearch Institute for Cell Engineering (RICE), National Institute of Advanced Industrial
Science and Technology (AIST), Japan
xDepartment of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Japan
Summary
Objectives: Human bone-marrow stromal cells are believed to be multipotent even in adults. This study assessed the effectiveness of autol-
ogous bone-marrow stromal cells, which were embedded within a collagen scaffold, to repair a full-thickness articular cartilage defect in the
medial femoral condyle of an athlete.
Patient and methods: A 31-year-old male judo player suffering from pain in the right knee was reviewed. A 20 30-mm full-thickness cartilage
defect (International Cartilage Repair Society classiﬁcation (ICRS) grade IV) was revealed in the weight-bearing area of the medial femoral
condyle. With the informed consent of the patient, the defect was treated with autologous bone-marrow stromal cells. Bone marrow was as-
pirated from the iliac crest of the patient 4 weeks before surgery. After removing the erythrocytes, the remaining cells were expanded in cul-
ture. Adherent cells were collected and embedded within a collagen gel, which was transferred to the articular cartilage defect in the medial
femoral condyle. The implant was covered with an autologous periosteal ﬂap.
Results: Seven months after surgery, arthroscopy revealed the defect to be covered with smooth tissues. Histologically, the defect was ﬁlled
with a hyaline-like type of cartilage tissue which stained positively with Safranin-O. One year after surgery, the clinical symptoms had improved
signiﬁcantly. The patient had reattained his previous activity level and experienced neither pain nor other complications.
Conclusions: Our ﬁndings indicate that the transplantation of autologous bone-marrow stromal cells can promote the repair of large focal ar-
ticular cartilage defects in young, active patients.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Articular cartilage defects have a poor capacity to undergo
self-repair, owing to the low mitotic potential of chondro-
cytes in vivo1. Since articular cartilage defects can progress
to osteoarthritis in some patients, they need to be repaired
even though their exact natural course remains obscure2e4.
Strategies that have been instigated to repair articular carti-
lage defects include microfractuing5 and mosaicplasty6,7.
However, these procedures are limited to small- and me-
dium-sized focal chondral and osteochondral defects. Mo-
saicplasty is also limited by the need to create defects at
donor sites, by an insufﬁcient repair result between the
grafts, and by the technical difﬁculties experienced in resur-
facing the original curvature of the joint6,7. The autologous
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formed by Peterson et al.8 in 1994. This was the ﬁrst appli-
cation of a cell-engineering strategy in orthopaedic surgery.
However, several problems are associated with the proce-
dure. These include difﬁculties in obtaining a sufﬁcient num-
ber of chondrocytes for autotransplantation, the necessity of
creating donor-site defects within autologous cartilage, and
poor histological repair1,6.
Mesenchymal stromal cells within the adult bone marrow
are multipotent, being capable of forming bone, cartilage
and other connective tissues9. It has been suggested that
these cells may be used effectively for the repair of cartilage
tissue. We report on a case of a focal articular cartilage in-
jury in an athlete. This study assessed the effectiveness of
autologous bone-marrow stromal cells to repair a full-thick-
ness articular cartilage defect in the medial femoral condyle
of a 31-year-old male judo player.
Case report
In 1999, a 31-year-old male judo player injured his right
knee whilst playing judo, and he underwent medial menis-
cectomy at another hospital. He resumed his judo activities26
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his knee whilst playing judo. He complained of pain in the
right knee and was referred to our hospital. His right knee
was remarkably swollen, and the active range of motion
was limited to extension. There were no signs of collateral
or cruciate ligament instability. X-radiography of the
weight-bearing knee in the standing position disclosed a ra-
diolucent area in the medial femoral condyle [Fig. 1(A)], but
the limb alignment was normal. Magnetic resonance imag-
ing (MRI) revealed a cartilage defect within the medial fem-
oral condyle, oedema of the subchondral bone, and
degeneration of the posterior part of the medial meniscus
[Fig. 2(A, B)]. Laboratory tests disclosed no abnormalities.
Arthroscopy revealed a 20 30-mm full-thickness carti-
lage defect (International Cartilage Repair Society classiﬁ-
cation (ICRS) grade IV) within the weight-bearing area of
the medial femoral condyle [Fig. 3(A)] and a macroscopic
tear in the middle third of the medial meniscus. A partial me-
niscectomy was performed, but the cartilage defect was left
untreated. In an attempt to repair the articular cartilage de-
fect, we decided to perform an autologous transplantation of
bone-marrow cells, with the informed consent of the patient.
Fifteen millilitres of bone marrow were aspirated from the
left iliac crest and transferred to tubes containing heparin-
ized phosphate-buffered saline. Four hundred millilitres of
the patient’s blood were collected. After centrifugation,
180 ml of serum were obtained. The cells derived from
3 ml of fresh bone marrow were transferred to two 75-cm2
plastic culture ﬂasks, within which they were maintained
for 4 weeks, with changes of medium (alpha minimal essen-
tial medium supplemented with 15% autologous serum)
three times per week. At the time when the medium was
changed, non-adherent haematopoietic cells were re-
moved. After about 10 days, the number of adherent cells
had increased to several million. The cells were collected
after trypsinization (ﬁrst passage) and further cultured (sub-
cultured) in other ﬂasks for about 10 days. At this stage,
they had a ﬁbroblast-like appearance. They were negative
for markers of haematopoietic cells (CD14, CD34) and for
HLA-DR, but positive for markers of mesenchymal ones
(CD73, CD90, CD105). These ﬁndings indicate that the ad-
herent cultured cells were of the mesenchymal type10. Thesubcultured cells were collected and suspended within
a 1% acid-soluble solution of porcine tendon type-I collagen
(ﬁnal cell density: 5 106 cells/ml). The collagenous cell
suspension was placed on a sheet of collagen (Gunze,
Kyoto, Japan), which acted as a support, and gelled at
37C. This gelecell composite was further cultured for
a couple of days. A small aliquot of medium collected at
the time of the last medium change was used to check for
bacterial and fungal contamination. These tests were nega-
tive. Hence, the composite was transplanted. The entire cul-
turing procedure was conducted at the Cell Processing
Center (CPC) of the National Institute of Advanced Indus-
trial Science and Technology (AIST). The CPC is an
ISO13485 certiﬁed facility.
Transplantation surgery was performed in September
2004. Following a medial para-patellar approach, all ﬁ-
brous tissue covering the surface of the defect was re-
moved. The subchondral bone was not stimulated. The
gelecell composite was introduced into the defect and
covered with an autologous periosteal ﬂap (harvested
from the anterior surface of the tibia), with the cambial
layer facing the bone marrow. The autologous periosteal
patch was afﬁxed to the surrounding rim of the normal car-
tilage with interrupted absorbable sutures. The knee was
immobilised for 10 days with a knee brace. Continuous
passive motion was initiated 11 days after surgery. Partial
weight-bearing was instigated 4 weeks, and full weight-
bearing 8 weeks after surgery.
Arthroscopy was performed 7 months after surgery. The
defect was completely covered with smooth tissues
[Fig. 3(B)], which appeared to have a ﬁrm consistency on
probing. Histologically, the defect was ﬁlledwith three distinct
layers of repaired tissue. The ﬁrst (superﬁcial) layer consisted
of ﬁbrous tissue and was presumably the periosteal patch.
The second (middle) layer was composed of a hyaline-like
type of cartilage tissue, which stained positively with both
Safranin-O and Toluidine Blue [Fig. 4(A, B)]. The third (lower)
layer was subchondral bone. Imaging at highermagniﬁcation
revealed cells within the middle layer to have a chondrocyte-
like appearance [Fig. 4(C)]. Immunohistochemistry for type-
II collagen revealed a positive reaction [Fig. 4(D)]. One year
after surgery, X-radiography disclosed no radiolucent areaFig. 1. (A) Anterioreposterior X-radiographic view of the weight-bearing knee before surgery. The image reveals a radiolucent area (*) within
the medial femoral condyle. (B) Anterioreposterior X-radiographic view of the weight-bearing knee 1 year after surgery. No radiolucent area is
now apparent within the medial femoral condyle.
228 R. Kuroda et al.: Implantation of bone-marrow stromal cells in an athleteFig. 2. (A, B) Magnetic resonance images before surgery. A defect is apparent within the medial femoral condyle, the subchondral bone is
oedematous, and the posterior portion of the medial meniscus has degenerated. (C, D) Magnetic resonance images 1 year after surgery.
The bone is no longer oedematous, but chondral and subchondral irregularities are apparent in the repaired area.
Fig. 3. (A) Arthroscopic ﬁndings before surgery. A 20 30-mm full-thickness cartilage defect (ICRS grade IV) is apparent within the weight-
bearing area of the medial femoral condyle. (B) Arthroscopic ﬁndings 7 months after surgery. The defect is completely covered with tissue,
which is a little softer than the surrounding articular cartilage.
229Osteoarthritis and Cartilage Vol. 15, No. 2Fig. 4. High-resolution imaging of the defect area 1 year after surgery. (A) Appearance of the tissue after staining with Safranin-O. Three dis-
tinct layers are apparent. The ﬁrst (upper) layer consists of ﬁbrous tissue, and is presumably the periosteal patch. The second (middle) layer is
composed of a hyaline-like type of cartilage tissue, which stains positively with Safranin-O. The third (lower) layer is subchondral bone. (B)
After treatment with Toluidine Blue, the middle layer stains metachromatically. (C) Higher-magniﬁcation view of the Toluidine-Blue-stained
middle layer of tissue revealing the chondrocyte-like appearance of the cells and an abundant extracellular matrix. (D) Immunohistochemical
staining of the tissue for type-II collagen reveals a positive reaction within the middle layer.[Fig. 1(B)]. However, MRI revealed focal chondral and sub-
chondral irregularities within the repaired area [Fig. 2(C,
D)]. Clinical symptoms had improved signiﬁcantly. The
patient had resumed his previous activity level and experi-
enced neither pain nor other complications.
Discussion
Articular cartilage has a poor intrinsic capacity for re-
pair11. Even a small defect caused by mechanical damage
will fail to heal. Indeed, it undergoes further degeneration
with time, often progressing to the debilitating condition of
osteoarthritis12,13.
Human bone-marrow stromal cells are believed to be
multipotent, and even in adults they have the potential to dif-
ferentiate into bone, cartilage, fat, tendon and muscle9.
When these cells are implanted within such defects, theyappear to be capable both of differentiating into articular
cartilage and of forming subchondral bone.
Defects that are conﬁned to the articular cartilage layer do
not heal spontaneously. The usual inﬂammatory response is
triggered, but an inferior, ﬁbrocartilaginous type of tissue is
formed. Techniques that have been instigated to treat arthri-
tis and chondral damage include abrasion14, bone-marrow
stimulation5, autografting, allografting and cell transplanta-
tion1. Recently, the ACI procedure was introduced1, and
has since been widely performed. However, the outcome
of this surgical treatment strategy is still controversial. Al-
though clinical symptoms improve, histological analyses
have revealed the repaired tissue to be insufﬁcient1,6.
The transplantation of culture-expanded bone-marrow
stromal cells has the advantage of not requiring an addi-
tional arthroscopic procedure to harvest articular cartilage,
and of being suitable for large focal cartilage defects. This
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volves no cell collection. The cells are collected under
conditions of local anaesthesia at an outpatient clinic.
Furthermore, neither bone nor cartilage defects are created
during the collection of the autologous bone-marrow stro-
mal cells, and these can proliferate without loosing their
capacity to differentiate15. Wakitani et al., who were the ﬁrst
to report good results after the transplantation of autologous
bone-marrow stromal cells in an animal model15, initiated
the procedure in humans. The reported cases include the
treatment of patellar cartilage defects16 and of osteoarthritic
knees undergoing high tibial osteotomy17. Histological anal-
yses revealed the defects to be repaired with ﬁbrocartilagi-
nous tissue16. In the present study, we report for the ﬁrst
time on the implantation of autologous bone-marrow stro-
mal cells within a focal cartilage defect of the weight-bearing
area of the medial femoral condyle in an athlete. The patient
has expressed his satisfaction with the outcome. Seven
months after transplantation, arthroscopy revealed the de-
fect to be completely ﬁlled with cartilaginous tissue and to
be covered with a smooth surface. At no location was the
subchondral bone exposed. The histological analysis re-
vealed the defect to be repaired with a hyaline-like type of
cartilage tissue which was rich in extracellular matrix. The
bony compartment of the defect was also repaired. We pre-
sume that the transplanted bone-marrow stromal cells
differentiated into both cartilage and bone. The result
achieved is notably better than the outcome reported by
other investigators who have applied the same technique
in humans16,17. After ACI, the repair tissue formed in the pa-
tella has been reported to be substantially inferior to that
laid down in the femoral condyle1. We consider that the re-
parative capacity of a chondral defect is linked to its topo-
graphic location. Appropriate mechanical conditions may
be necessary to provide a suitable environment for the
synthesis of an extracellular-matrix-rich cartilage16. Further-
more, it has been postulated that the formation of ﬁbrocar-
tilage may be inhibited by preventing bleeding from the
subchondral bone. Most mesenchymal tissues derive their
nutrients from a well-developed network of capillaries. But
cartilage is normally devoid of capillary networks and,
except during endochondral bone formation, is resistant to
vascular invasion from surrounding tissues18. Since the
vascular barrier is broken down in full-thickness cartilage
defects, various cells and cytokines, including ﬁbroblasts,
haematopoietic stem cells and angiogenic growth factors,
would invade the damaged cartilage if the subchondral
bone were stimulated. In our case, the subchondral bone
was not stimulated. Hence, the environment favoured carti-
lage regeneration. In previous reports, the tissue derived
from implanted chondrocytes was not invaded by vessels
or replaced by subchondral bone, and the repair cartilage
maintained its thickness throughout the depth of the original
defect19,20. These ﬁndings may also reﬂect an absence of
bone stimulation.
The standard set for full healing is high, and has not yet
been achieved. Promising approaches could involve the
combination of bone-marrow stromal cells with various scaf-
folds and growth factors, using either recombinant proteins
or the gene-therapy approach. Although further studies with
a large number of patients and longer follow-up periods are
required to investigate the long-term efﬁcacy of this proce-
dure, the conclusion of our study is that the transplantation
of autologous bone-marrow stromal cells is an acceptable
procedure to treat full-thickness focal chondral defects of
critical size (2e10 cm2) in young (15e50 years of age), ac-
tive patients, including athletes.References
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